Flossbach Von Storch AG lessened its stake in Colgate-Palmolive Company (NYSE:CL) by 22.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 292,970 shares of the company’s stock after selling 83,700 shares during the period. Flossbach Von Storch AG’s holdings in Colgate-Palmolive were worth $21,718,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Harbour Capital Advisors LLC increased its position in Colgate-Palmolive by 7,313.0% in the 2nd quarter. Harbour Capital Advisors LLC now owns 123,056 shares of the company’s stock valued at $1,660,000 after acquiring an additional 121,396 shares during the period. First Merchants Corp increased its position in Colgate-Palmolive by 2.0% in the 2nd quarter. First Merchants Corp now owns 24,167 shares of the company’s stock valued at $1,792,000 after acquiring an additional 480 shares during the period. IBM Retirement Fund increased its position in Colgate-Palmolive by 117.5% in the 2nd quarter. IBM Retirement Fund now owns 21,086 shares of the company’s stock valued at $1,746,000 after acquiring an additional 11,391 shares during the period. NGAM Advisors L.P. increased its position in Colgate-Palmolive by 1.4% in the 2nd quarter. NGAM Advisors L.P. now owns 112,452 shares of the company’s stock valued at $8,336,000 after acquiring an additional 1,561 shares during the period. Finally, Sumitomo Life Insurance Co. increased its position in Colgate-Palmolive by 4.4% in the 2nd quarter. Sumitomo Life Insurance Co. now owns 30,481 shares of the company’s stock valued at $2,260,000 after acquiring an additional 1,285 shares during the period. Hedge funds and other institutional investors own 73.10% of the company’s stock.

Several brokerages recently issued reports on CL. Macquarie began coverage on Colgate-Palmolive in a research report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price target on the stock. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday. BidaskClub cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Royal Bank Of Canada restated a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research report on Thursday, May 25th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research report on Thursday, August 24th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. Colgate-Palmolive presently has a consensus rating of “Hold” and an average target price of $75.83.

In related news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total transaction of $273,867.85. Following the transaction, the insider now owns 53,173 shares in the company, valued at $3,799,210.85. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Vice Chairman Franck J. Moison sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $71.52, for a total transaction of $2,503,200.00. Following the transaction, the insider now owns 201,411 shares in the company, valued at approximately $14,404,914.72. The disclosure for this sale can be found here. Insiders have sold 217,969 shares of company stock worth $15,693,933 in the last quarter. Company insiders own 1.02% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Flossbach Von Storch AG Sells 83,700 Shares of Colgate-Palmolive Company (CL)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/21/flossbach-von-storch-ag-sells-83700-shares-of-colgate-palmolive-company-cl.html.

Shares of Colgate-Palmolive Company (NYSE:CL) opened at 72.55 on Thursday. The stock’s 50 day moving average price is $71.58 and its 200 day moving average price is $73.27. The stock has a market cap of $63.91 billion, a price-to-earnings ratio of 26.96 and a beta of 0.80. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same quarter last year, the business earned $0.70 earnings per share. Colgate-Palmolive’s revenue was down .5% compared to the same quarter last year. Equities research analysts anticipate that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.